Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars - 2The next frontier in space is closer than you think – welcome to the world of very low Earth orbit satellites
- 3Knesset sets special panel to fast-track Karhi’s communications reform
- 4King Charles III says he is reducing cancer treatment schedule in 2026
- 5Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- Reporter's Notebook: The Post embeds with foreign armies visiting the IDF
- Instructions to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- Israel kidnaps PIJ terrorist in covert op. in Hamas-controlled Gaza in pursuit of Ran Gvili
- Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist
- There are thousands of aligned holes in Peru. Archaeologists now think they know who made them
- As tetanus vaccination rates decline, doctors worry about rising case numbers
- Vote In favor of Your Favored Sort Of Bevarage
- Americans generally like wolves − except when we’re reminded of our politics
- Financial plan Cordial Home Redesigns That Add Worth
